MP12: Kidney Cancer: Advanced (including Drug Therapy) I

Poster Session Moderator(s)

• 

  Sarah Psutka, MD, MS (she/her/hers)

  Associate Professor
  University of Washington, Fred Hutchinson Cancer Center
• VM

  Vitaly Margulis, MD

  UT Southwestern Medical Center
• 

  Michael Whalen, MD

  George Washington University School of Medicine & Health Science

Presentations:

• 1:00 PM – 2:15 PM

  MP12-01: C-reactive protein kinetics to predict recurrence after radical surgery for high-risk renal cell carcinoma
  

  Poster Presenter: Yudai Ishiyama, MD
• 1:00 PM – 2:15 PM

  MP12-02: Prospective evaluation of circulating tumor DNA (ctDNA) in detecting early progression on immune checkpoint inhibitors in patients with advanced genitourinary cancers
  

  Poster Presenter: Albert Jang, MD – Tulane University School of Medicine
• 1:00 PM – 2:15 PM

  MP12-03: IL-7 and CCL19 producing CAR-T cells prevent antigen-loss tumor relapse and enhance antitumor efficacy against solid cancer
  

  Poster Presenter: Shunsuke Goto, MD, PHD – Kyushu University
• 1:00 PM – 2:15 PM

  MP12-04: Predictive impact of early changes in serum C-reactive protein levels in nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma
  

  Poster Presenter: Hidekazu Tachibana, MD, PHD
• 1:00 PM – 2:15 PM

  MP12-05: Psoas muscle mass predicts the outcome of nivolumab treatment for renal cell carcinoma
  

  Poster Presenter: Hideto Ueki
• 1:00 PM – 2:15 PM

  MP12-06: Oncologic outcomes in patients diagnosed with pT3aN0M0 renal cell cancer according to renal vein thrombus or fat invasion
  

  Poster Presenter: Giuseppe Basile, MD
• 1:00 PM – 2:15 PM

  MP12-07: The anatomical location of lymphadenopathies at imaging predicts the risk of lymph node invasion at final pathology in patients with renal cell carcinoma
  

  Poster Presenter: Giuseppe Rosiello, MD – San Raffaele Hospital
• 1:00 PM – 2:15 PM

  MP12-08: Outcomes of Nephrectomy for Renal Cell Carcinoma with Venous Thrombus Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study
  

  Poster Presenter: Alireza Ghoreifi, MD – USC
• 1:00 PM – 2:15 PM

  MP12-09: Prognostic model of upfront cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with immune-checkpoint inhibitors and/or tyrosine kinase inhibitors.
  

  Poster Presenter: Jun Teishima
• 1:00 PM – 2:15 PM

  MP12-10: Potential survival benefit of deferred nephrectomy in patients treated with nivolumab plus ipilimumab for metastatic renal cell carcinoma
  

  Poster Presenter: Maki Yoshino, MD
• 1:00 PM – 2:15 PM

  MP12-11: Neoadjuvant therapy in the management of local retroperitoneal recurrence of renal cell carcinoma after radical nephrectomy
  

  Poster Presenter: Jiwei Huang
• 1:00 PM – 2:15 PM

  MP12-12: Surgical Management and oncologic outcomes for Local Retroperitoneal Recurrence Of Renal Cell Carcinoma After Radical Nephrectomy
  

  Poster Presenter: Jiwei Huang
• 1:00 PM – 2:15 PM

  MP12-13: The role of nephrectomy in metastatic renal cell carcinoma in the era of immune-combination therapies: a meta-analysis
  

  Poster Presenter: Keiichiro Mori, MD, PhD
• 1:00 PM – 2:15 PM

  MP12-14: Site-specific early response patterns in advanced RCC patients treated with Nivolumab and Ipilimumab compared with Sunitinib therapy
  

  Poster Presenter: Renpei Kato – Iwate Medical University
• 1:00 PM – 2:15 PM

  MP12-15: Effects of first-line immune checkpoint inhibitors in patients with metastatic renal cell carcinoma not meeting trial eligibility criteria
  

  Poster Presenter: Yuki Nemoto, MD – Tokyo Women's Medical University Adachi Medical Ce
• 1:00 PM – 2:15 PM

  MP12-16: Optimizing targeted drug selection in combination therapy for patients with advanced or metastatic renal cell carcinoma: a systematic review and network meta-analysis of safety
  

  Poster Presenter: Ruiyang Xie – National Cancer Center/National Clinical Research
• 1:00 PM – 2:15 PM

  MP12-17: Immunotherapy-based Combinations in the First-line Treatment of Metastatic Renal Cell Carcinoma with Sarcomatoid Features: A Systematic Review and Network Meta-analysis
  

  Poster Presenter: Fahad Quhal, MD – King fahad specialist hospital in Dammam
• 1:00 PM – 2:15 PM

  MP12-18: Immune-related adverse events associated with better survival outcomes for metastatic renal cell carcinoma treated with nivolumab plus ipilimumab
  

  Poster Presenter: Kazuyuki Numakura, MD
• 1:00 PM – 2:15 PM

  MP12-19: Adjuvant systemic treatment for renal cancer after surgery: a network meta-analysis
  

  Poster Presenter: Niranjan Sathianathen
• 1:00 PM – 2:15 PM

  MP12-20: First-Line Immunotherapy-Based Combinations for Metastatic Renal Cell Carcinoma: Systematic Review and Network Meta-Analysis
  

  Poster Presenter: Fahad Quhal, MD – King fahad specialist hospital in Dammam